Business Standard

Germany to discuss AstraZeneca Covid-19 shots after blood clot reports

Health Minister Jens Spahn will talk with his regional counterparts at 1800 CET (1600 GMT), a ministry spokesman said

AstraZeneca, pharma, coronavirus, vaccine
Premium

AstraZeneca says its vaccine is safe and effective, citing extensive trial data. Millions of doses have been safely administered around the world

Reuters Berlin
German leaders will discuss the use of AstraZeneca's COVID-19 vaccine on Tuesday, after several states said they would stop giving the shot to people under the age of 60 following further reports of a rare brain blood disorder.
 
Health Minister Jens Spahn will talk with his regional counterparts at 1800 CET (1600 GMT), a ministry spokesman said.
 
The meeting follows further reports by Germany's vaccine regulator, the Paul Ehrlich Institute (PEI), of cases of blood clots known as cerebral sinus vein thrombosis (CSVT).
 
Germany's vaccine committee, known as STIKO, will recommend using the Anglo-Swedish shot only in people over 60,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in